It is generally asserted that price discrimination is a common feature of the international pharmaceutical market, resulting in unnecessarily high medical costs to developing countries, since it is pharmaceuticals that are the largest component of their health care expenditures. However, little comprehensive empirical research has been carried out to test this hypothesis.

ISS Staff Group 0
World Development
International Institute of Social Studies of Erasmus University (ISS)

Schut, F.T, & van Bergeijk, P.A.G. (1986). International Price Discrimination: The Pharmaceutical Industry. World Development, 14(9), 1141–1150. Retrieved from